TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

A multicentre observational study on treatment approaches and HER2 positive status prevalence in different stages of bladder cancer and PD-L1-positive status in metastatic bladder cancer in Russian Federation

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Wiek co najmniej 18 lat
  • Potwierdzony rak pęcherza moczowego (na dowolnym etapie zaawansowania)
  • Zgoda na pobranie próbki tkanki guza do badań
  • Dla pacjentów we wczesnym stadium: zabieg endoskopowy wykonany 1-12 miesięcy przed badaniem
  • Dla pacjentów w średnio zaawansowanym stadium: operacja usunięcia pęcherza wykonana 2-12 miesięcy przed badaniem
  • Dla pacjentów z przerzutami: diagnoza postawiona w ciągu ostatnich 12 miesięcy
  • Dostępne dane z historii medycznej pacjenta
  • Dostępna próbka tkanki guza z biopsji lub operacji

✗ Disqualifies

  • Jednoczesny udział w innym badaniu klinicznym od czasu rozpoznania raka pęcherza

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
August 10, 2026
Sex
No restrictions

Locations (20)

Research Site

Arkhangelsk, Russia

Research Site

Barnaul, Russia

Research Site

Chelyabinsk, Russia

Research Site

Krasnodar, Russia

Research Site

Krasnoyarsk, Russia

Research Site

Makhachkala, Russia

Research Site

Moscow, Russia

Research Site

Moscow, Russia

Research Site

Moscow, Russia

Research Site

Nizhny Novgorod, Russia

Research Site

Novosibirsk, Russia

Research Site

Obninsk, Russia

Research Site

Omsk, Russia

Research Site

Saint Petersburg, Russia

Research Site

Saint Petersburg, Russia

Research Site

Saint Petersburg, Russia

Research Site

Tomsk, Russia

Research Site

Tyumen, Russia

Research Site

Ufa, Russia

Research Site

Yekaterinburg, Russia

Trial contact

AstraZeneca Clinical Study Information Center

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/11/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.